Top Technologies in Health and Wellness, 2017

Top technology trends that are likely to have an impact in 2017

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

This strategic research service, Health & Wellness Top 10 Technologies, depicts the current landscape and the new trends in a series of developments associated with innovations in Precision Oncology, Biobetters,Human Microbiomics, Immune Engineering, Cancer/Tumor Profiling, Cellular Therapeutics, Tissue Engineering, Molecular Diagnostics, Gene Editing and Predictive Biomarkers.

Techvision's professionals have monitored, gathered, and analyzed numerous emerging and disruptive technologies selecting this top 10 technologies, by contacting an extensive network of innovators, technology developers, financial institutions, technologists and researchers, among other players in the ecosystem, with the aim to provide your company or institution with a notable intelligence work that can help you build and implement strong growth strategies by leverage disruptive technologies and emerging innovations.

Table of Contents

1.0 Executive Summary 1.1 Research Scope and Index1.2 Selection Methodology1.3 Assessment of Top Technologies: 2015 and 20161.4 Global Health & Wellness Trends Across 2017 1.5 Key Findings 1.5 Key Findings (continued)2.0 Precision Oncology2.1 Precision Medicine Advances Likely to Disrupt Existing Cancer Management Landscape in the Future 2.2 Big Pharma Likely to Lead Global Precision Oncology Innovations2.3 Precision Oncology Likely to Witness Continued Growth in IP and Funding Activities2.4 Precision Medicine Innovations Likely to Transform Global Cancer Management Landscape3.0 Molecular Diagnostics3.1 Next-generation Sequencing Technologies Likely to Disrupt Existing Molecular Diagnostic Platforms3.2 Emerging Molecular Diagnostic Platforms Present a Growing Market Opportunity3.3 US Leads the Patent and Funding Landscape for MDx Innovations3.4 Emerging NGS Platforms Likely to Transform Global MDx Landscape4.0 Predictive Biomarkers4.1 Predictive Biomarker Technologies Lead Personalized Medicine Platforms4.2 US Leads the IP Landscape for Predictive Biomarkers4.3 Personalized Genomics Start-ups Lead the Venture Landscape4.4 Genomic Tests Likely to Lead Biomarker Enabling Platforms5.0 Cancer/Tumor Profiling5.1 Liquid Biopsy Profiling Platforms Likely to Disrupt Tumor Tissue Biopsy Techniques5.2 Tumor Profiling Market Poised for Continued Growth5.3 US Leads the IP Landscape for Tumor Profiling5.4 Liquid Biopsy Startups Dominate the Venture Landscape5.5 Liquid Biopsy Techniques likely to Transform Early Tumor Screening6.0 Cellular Therapeutics6.1 Stem Cell Therapy is Expected to Address the Most Crucial Medical Challenges6.2 The Stem Cell Therapy Field is Very Active In Terms Of New Companies Significantly Impacting the Market by 20216.3 Stem Cells Paving the Way for Precision Medicine Through an Unprecedented Technology Synergy6.4 New Japanese Regulatory Framework Impacting Healthcare Globally7.0 Gene Editing7.1 Gene Editing Techniques Paving the way for Disease Research and Novel Therapeutics7.2 CRISPR-Cas9 Gene Editing Technology Will Significantly Impact the Market by 20217.3 Gene Editing Techniques Paving the Way for Precision Medicine7.4 North America and Europe are Dominating the Gene Editing Market8.0 Human Microbiomics8.1 Microbiomics Impacts Key Consumer Benefit Areas Such as Skin and Gut Health 8.2 Diversity of Market Potential Provides Multiple Opportunities for Rapid Growth8.3 US-based Inventors are Leading in Microbiome-Focused R&D8.4 Skincare, GI, and Immunity are Key Consumer Benefit Areas for Microbiome-Focused Products9.0 Immune Engineering 9.1 Immunotherapy Is Pushing the Barriers of Standard Cancer Therapy9.2 Replacing Chemotherapy as First-line Treatment Option Increases Revenue Potential of Immunotherapies 9.3 US-Based Inventors are Leading In Immune-Focused R&D9.4 Immuno-oncology Is the Largest Application Segment Present Under Immunotherapy10.0 Follow on Biologics: Biobetters10.1 Biobetters: A Whole New Generation of Biosimilars 10.2 Greater Adoption of Biosimilars Directly Impact by the Degree of Pharmaceutical Involvement 10.3 Patenting across Biosimilars Largely Happens around Process and Production Techniques 10.4 Oncology is Currently the Disease Area Getting Impacted the Most by Biosimilars 11.0 Tissue Engineering11.1 Tissue Engineering Has Become a Promising Field among the Foremost Innovative Areas of Medical Care Today11.2 3D Bioprinting Technology is Expected to Have Greatest Impact in the Market by 202511.3 Additional Commercial Opportunities in Assembly, Manufacturing, and Drug Delivery Sectors11.4 Regional Differentiation Approaches Make the Tissue Engineering Sphere Highly DynamicLegal Disclaimer12.0 The Frost & Sullivan Story12.1 The Frost & Sullivan Story12.2 Value Proposition: Future of Your Company & Career12.3 Global Perspective12.4 Industry Convergence12.5 360º Research Perspective12.6 Implementation Excellence12.7 Our Blue Ocean Strategy




Related Research

Release Date : 19-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.